[1] |
LIU Rui, CAO Yu, CHU Aiqun, WU Huanyun.
Current Situation of Community Pharmacy Services and the Integration of Pharmacists into Family Doctor Team in Shanghai
[J]. Chinese General Practice, 2023, 26(31): 3922-3929.
|
[2] |
WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan.
Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease
[J]. Chinese General Practice, 2023, 26(17): 2155-2161.
|
[3] |
Chinese Society of Osteoporosis and Bone Mineral Research.
Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)
[J]. Chinese General Practice, 2023, 26(14): 1671-1691.
|
[4] |
YAO Huijuan, YANG Yu, XU Ajing.
Interpretation of Diabetes Management in Chronic Kidney Disease: a Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
[J]. Chinese General Practice, 2023, 26(12): 1415-1421.
|
[5] |
SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi.
Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer
[J]. Chinese General Practice, 2023, 26(02): 241-247.
|
[6] |
ZENG Yuan, WANG Guohua, YANG Yong.
Curative Effect of Patient-controlled Intravenous Analgesia with Hydromorphone, Sufentanil or Morphine in Treatment of Refractory Cancer Pain with Dysphagia
[J]. Chinese General Practice, 2022, 25(36): 4537-4545.
|
[7] |
TANG Yu, TAN Huiwen, LI Jianwei, YU Yerong.
Interpretation of Consensus on Diagnosis and Management of Cushing's Disease: a Guideline Update from the Pituitary Society——Medical Therapies
[J]. Chinese General Practice, 2022, 25(36): 4483-4490.
|
[8] |
ZHOU Qinfei, GONG Liyan.
Clinical Observation of the Effectiveness of Methadone in Refractory Carcinous Pain Patients
[J]. Chinese General Practice, 2022, 25(32): 4023-4028.
|
[9] |
Zhenwei LIU, Wenhui WU, Manhua QIAO, Muhan CHEN, Cao WANG, Qi TANG, Jun LYU, Gang CHEN.
Needs of Pharmaceutical Care in the Community of Shanghai
[J]. Chinese General Practice, 2022, 25(28): 3556-3561.
|
[10] |
Manhua QIAO, Wenhui WU, Zhenwei LIU, Muhan CHEN, Cao WANG, Qi TANG, Jun LYU, Gang CHEN.
Community Pharmaceutical Services Implemented in Shanghai
[J]. Chinese General Practice, 2022, 25(28): 3562-3568.
|
[11] |
Pengxiang ZHANG, Lin ZENG, Lu MENG, Qian HUANG, Gaoxiang WANG, Deliang LIU.
New Research Progress of the Novel Target Drugs for the Treatment of Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2022, 25(20): 2551-2557.
|
[12] |
Ling LI, Huijuan ZHANG.
Recent Developments in Pituitary-directed Medical Treatment for Cushing's Disease
[J]. Chinese General Practice, 2022, 25(14): 1789-1794.
|
[13] |
CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia.
Clinical Study of Venetoclax with
Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
[J]. Chinese General Practice, 2022, 25(08): 957-962.
|
[14] |
YANG Rongjun, SHI Yufang, WANG Qinghai.
Advances in Mechanism of Coexistence and
Pharmaceutical Treatment of Chronic Heart Failure and Depression
[J]. Chinese General Practice, 2022, 25(05): 625-630.
|
[15] |
WU Xingwei, LIU Xinyu, LONG Enwu, TONG Rongsheng.
Research Progress of Machine Learning in
Clinical Drug Therapy
[J]. Chinese General Practice, 2022, 25(02): 254-258.
|